Article Details

CEPI, AstraZeneca announce deal to develop novel antibody | CIDRAP

Retrieved on: 2025-03-20 20:07:26

Tags for this article:

Click the tags to see associated articles and topics

CEPI, AstraZeneca announce deal to develop novel antibody | CIDRAP. View article details on hiswai:

Summary

The article discusses CEPI's collaboration with AstraZeneca to develop VHH antibodies, which are derived from sharks and other animals. These antibodies, relevant to immunology and the immune system, aim to offer an affordable monoclonal antibody alternative for pandemic flu.

Article found on: www.cidrap.umn.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo